thioctic acid has been researched along with bortezomib in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; Chen, H; Han, X; Huang, Y; Liu, J; Peng, C; Rao, L; Ren, Y; Sheng, C; Su, C; Tu, J; Wan, C; Wan, J; Wen, W | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Aldini, G; Altomare, A; Fusi, C; Geppetti, P; Lodovici, M; Materazzi, S; Nassini, R; Patacchini, R; Trevisan, G | 1 |
| Bossaer, JB | 1 |
| Amenta, F; Anfuso, CD; Avola, R; Bramanti, V; Brundo, MV; Camiolo, G; Cristaldi, M; Giallongo, C; Li Volti, G; Lupo, G; Puglisi, F; Stampone, T; Tibullo, D; Tomassoni, D | 1 |
| Galiè, E; Giannarelli, D; Gumenyuk, S; Maialetti, A; Marchesi, F; Maschio, M; Mengarelli, A; Pisani, F; Renzi, D; Zarabla, A | 1 |
| Istenes, I; Kőhidai, L; Lajkó, E; Láng, O; Takács, A | 1 |
7 other study(ies) available for thioctic acid and bortezomib
| Article | Year |
|---|---|
Structure-Guided Discovery of the Novel Covalent Allosteric Site and Covalent Inhibitors of Fructose-1,6-Bisphosphate Aldolase to Overcome the Azole Resistance of
Topics: Allosteric Site; Antifungal Agents; Azoles; Biofilms; Candida albicans; Candida parapsilosis; Drug Resistance, Fungal; Enzyme Inhibitors; Fructose-Bisphosphate Aldolase; Fungal Proteins; Microbial Sensitivity Tests; Molecular Structure; Protein Binding; Structure-Activity Relationship | 2022 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Novel therapeutic strategy to prevent chemotherapy-induced persistent sensory neuropathy by TRPA1 blockade.
Topics: Acetanilides; Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Mice; Mice, Inbred C57BL; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Purines; Pyrazines; Thioctic Acid; Transient Receptor Potential Channels; TRPA1 Cation Channel | 2013 |
Addressing potential interactions between antineoplastics and dietary supplements.
Topics: Antineoplastic Agents; Bortezomib; Dietary Supplements; Drug Information Services; Drug Interactions; Humans; Thioctic Acid | 2015 |
Effect of Lipoic Acid on the Biochemical Mechanisms of Resistance to Bortezomib in SH-SY5Y Neuroblastoma Cells.
Topics: Apoptosis; Bortezomib; Cell Line, Tumor; Cell Nucleus; Drug Resistance, Neoplasm; Endoplasmic Reticulum Stress; Humans; Neoplasm Proteins; Neuroblastoma; Protein Transport; Signal Transduction; Thioctic Acid | 2018 |
Prevention of Bortezomib-Related Peripheral Neuropathy With Docosahexaenoic Acid and α-Lipoic Acid in Patients With Multiple Myeloma: Preliminary Data.
Topics: Aged; Antineoplastic Agents; Bortezomib; Docosahexaenoic Acids; Female; Humans; Male; Middle Aged; Multiple Myeloma; Peripheral Nervous System Diseases; Quality of Life; Thioctic Acid; Treatment Outcome | 2018 |
Alpha-lipoic acid alters the antitumor effect of bortezomib in melanoma cells in vitro.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Bortezomib; Cell Cycle; Cell Line, Tumor; Humans; Hydrogen Peroxide; Melanoma; Oxidative Stress; Proteasome Endopeptidase Complex; Reactive Oxygen Species; Thioctic Acid | 2020 |